Similar articles for PMID: 36657982

Year	Number of Results
2004	1
2005	1
2010	1
2013	1
2014	1
2015	6
2016	10
2017	10
2018	12
2019	25
2020	23
2021	20
2022	14
2023	4

1

Consecutive PSMA and AR PET imaging shows positive correlation to AR and PSMA protein expression in primary hormone naïve prostate cancer.

Al Jalali V, Wasinger G, Rasul S, Grubmueller B, Wulkersdorfer B, Balber T, Mitterhauser M, Simon J, Hacker M, Shariat S, Egger G, Zeitlinger M. Al Jalali V, et al. J Nucl Med. 2023 Jan 19:jnumed.122.264981. doi: 10.2967/jnumed.122.264981. Online ahead of print. J Nucl Med. 2023. PMID: 36657982

2

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

3

Healthy Tissue Uptake of ⁶⁸Ga-Prostate-Specific Membrane Antigen, ¹⁸F-DCFPyL, ¹⁸F-Fluoromethylcholine, and ¹⁸F-Dihydrotestosterone.

Jansen BHE, Kramer GM, Cysouw MCF, Yaqub MM, de Keizer B, Lavalaye J, Booij J, Vargas HA, Morris MJ, Vis AN, van Moorselaar RJA, Hoekstra OS, Boellaard R, Oprea-Lager DE. Jansen BHE, et al. J Nucl Med. 2019 Aug;60(8):1111-1117. doi: 10.2967/jnumed.118.222505. Epub 2019 Jan 10. J Nucl Med. 2019. PMID: 30630941 Free PMC article.

4

Synthesis and Evaluation of ¹⁸F-Enzalutamide, a New Radioligand for PET Imaging of Androgen Receptors: A Comparison with 16β-¹⁸F-Fluoro-5α-Dihydrotestosterone.

Antunes IF, Dost RJ, Hoving HD, van Waarde A, Dierckx RAJO, Samplonius DF, Helfrich W, Elsinga PH, de Vries EFJ, de Jong IJ. Antunes IF, et al. J Nucl Med. 2021 Aug 1;62(8):1140-1145. doi: 10.2967/jnumed.120.253641. Epub 2021 Jan 30. J Nucl Med. 2021. PMID: 33517325 Free article.

5

Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies.

Venema CM, Mammatas LH, Schröder CP, van Kruchten M, Apollonio G, Glaudemans AWJM, Bongaerts AHH, Hoekstra OS, Verheul HMW, Boven E, van der Vegt B, de Vries EFJ, de Vries EGE, Boellaard R, Menke van der Houven van Oordt CW, Hospers GAP. Venema CM, et al. J Nucl Med. 2017 Dec;58(12):1906-1912. doi: 10.2967/jnumed.117.193649. Epub 2017 Sep 14. J Nucl Med. 2017. PMID: 28912144 Free article. Clinical Trial.

6

[¹⁸F]-FDHT PET/CT as a tool for imaging androgen receptor expression in high-grade glioma.

Orevi M, Shamni O, Zalcman N, Chicheportiche A, Mordechai A, Moscovici S, Shoshan Y, Shahar T, Charbit H, Gutreiman M, Paldor I, Mishani E, Lossos A, Lavon I. Orevi M, et al. Neurooncol Adv. 2021 Jan 29;3(1):vdab019. doi: 10.1093/noajnl/vdab019. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 33738450 Free PMC article.

7

Specific ¹⁸F-FDHT Accumulation in Human Prostate Cancer Xenograft Murine Models Is Facilitated by Prebinding to Sex Hormone-Binding Globulin.

Larimer BM, Dubois F, Bloch E, Nesti S, Placzek M, Zadra G, Hooker JM, Loda M, Mahmood U. Larimer BM, et al. J Nucl Med. 2018 Oct;59(10):1538-1543. doi: 10.2967/jnumed.118.208785. Epub 2018 May 31. J Nucl Med. 2018. PMID: 29853654 Free article.

8

⁶⁸Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour.

Uprimny C, Kroiss AS, Decristoforo C, Fritz J, von Guggenberg E, Kendler D, Scarpa L, di Santo G, Roig LG, Maffey-Steffan J, Horninger W, Virgolini IJ. Uprimny C, et al. Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):941-949. doi: 10.1007/s00259-017-3631-6. Epub 2017 Jan 31. Eur J Nucl Med Mol Imaging. 2017. PMID: 28138747

9

Serial [¹⁸F]-FDHT-PET to predict bicalutamide efficacy in patients with androgen receptor positive metastatic breast cancer.

Boers J, Venema CM, de Vries EFJ, Hospers GAP, Boersma HH, Rikhof B, Dorbritz C, Glaudemans AWJM, Schröder CP. Boers J, et al. Eur J Cancer. 2021 Feb;144:151-161. doi: 10.1016/j.ejca.2020.11.008. Epub 2020 Dec 18. Eur J Cancer. 2021. PMID: 33341447 Free article. Clinical Trial.

10

Imaging Androgen Receptors in Breast Cancer with ¹⁸F-Fluoro-5α-Dihydrotestosterone PET: A Pilot Study.

Jacene H, Liu M, Cheng SC, Abbott A, Dubey S, McCall K, Young D, Johnston M, Van den Abbeele AD, Overmoyer B. Jacene H, et al. J Nucl Med. 2022 Jan;63(1):22-28. doi: 10.2967/jnumed.121.262068. Epub 2021 May 28. J Nucl Med. 2022. PMID: 34049982 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed